Sanofi-Aventis has launched new production units at its Le Trait injectables manufacturing site near Rouen, France. The company has invested €87 million in the facility over the past three years. One million syringes are produced at the site each day, and around 90% of these are exported, 25% of which to the North American market.
The new production lines include filling, inspection and packaging systems, which will enable the company to double its production of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?